Introduction: Clinical practice guidelines increasingly favor a more symptom-driven approach to maintenance dialysis initiation. But, little is known about the clinical presentation at dialysis initiation, such as the different kinds of signs and symptoms present at dialysis initiation, illness acuity at dialysis initiation, and how these aspects of the clinical presentation relate to subsequent survival. Methods: This is a retrospective cohort study of a random sample of veterans who initiated dialysis between 2000 and 2009 at Veterans Affairs (VA) medical centers across the country (N = 1,691). We looked at associations between the clinical presentation (types of signs and/or symptoms and illness acuity) at the time of dialysis initiation and 1-year mortality. Findings: The most common types of signs and/or symptoms at initiation were gastrointestinal (50.9%) and cardiopulmonary (48.7%). The crude mortality rate was 174.2 deaths per 1000 patients per year (95% CI 154.7, 196.1). Among different categories of signs and/or symptoms, only cardiopulmonary signs and/or symptoms were associated with a higher 1-year risk of mortality after initiation (risk ratio (RR) 1.32, 95% CI 1.05, 1.69) in adjusted analyses. Patients who were acutely ill at initiation were more likely to die during the following year as compared with those who initiated dialysis in the outpatient setting (RR 1.57, 95% CI 1.15, 2.21). Discussion: With the exception of cardiopulmonary signs and/or symptoms, most signs and/or symptoms documented around the time of dialysis initiation were not associated with an increased risk of death during the year after initiation. In contrast, whether patients were acutely ill at the time 106 of initiation was strongly associated with an increased risk of death after initiation regardless of the specific signs and/or symptoms present. Limitations of this study include retrospective study design, residual confounding, and lack of generalizability to non-VA settings.
INTRODUCTION
In the United States, nearly half a million Americans receive maintenance dialysis for end-stage renal disease (ESRD) and the annual costs to the Medicare ESRD program of caring for these patients are estimated to be over $30 billion. 1 While dialysis prolongs life for many patients, chronic dialysis is a time-intensive and potentially burdensome treatment that does not always restore health. 2, 3 Weighing the potential benefits and burdens of dialysis for individual patients can be extremely challenging 4 and there is often substantial uncertainty about whether and when to initiate maintenance dialysis in individual patients.
Prior research has focused on timing of dialysis initiation in relation to level of kidney function, or estimated glomerular filtration rate (eGFR). While observational data suggested that level of kidney function at the time of initiation might be an important determinant of mortality after initiation, [5] [6] [7] [8] [9] [10] a large randomized controlled trial of dialysis timing based on eGFR, the initiating dialysis early and late (IDEAL) trial, found no differences in survival, cardiovascular events, or dialysis complications between patients randomized to eGFR targets of 10-14 vs. 5-7 mL/min/1.73 m 2 at dialysis initiation. 11 Earlier initiation of dialysis in IDEAL was associated with increased health care costs but not with improved quality of life. 12 In response to the results of this trial suggesting no benefit to earlier initiation of dialysis at higher levels of eGFR, clinical practice guidelines have moved away from an eGFR-based approach to initiation and now suggest that dialysis should be considered when patients with advanced kidney disease start to develop signs and symptoms classically associated with uremia, rather than at a specific level of kidney function or eGFR. 13 However, a symptom-based approach to dialysis initiation may be challenging in complex patients who may have symptoms from other comorbid conditions or medications. Limited data are currently available on the frequency and prognostic implications of the signs and symptoms of advanced kidney disease around the time of dialysis initiation. 14, 15 A single center study found that patients who initiated dialysis for volume overload or hypertension had higher all-cause mortality compared to patients who initiated dialysis for laboratory evidence of kidney function decline; in contrast, there was no increased mortality for patients who initiated dialysis for other uremic symptoms. 16 However, this study did not evaluate whether different types of uremic symptoms or acuity of care at the time of dialysis initiation may be associated with mortality. As uremic symptoms can manifest with both life-threatening and non-life threatening presentations (e.g., patients can present with cardiopulmonary symptoms that range from lower extremity edema to uremic pericarditis), we hypothesized that the prognostic value of different signs and symptoms of advanced kidney disease might need to be interpreted in clinical context, and that more detailed information on the patient's clinical presentation around the time of dialysis initiation may be helpful in estimating prognosis.
The purpose of this study was to describe the characteristics and outcomes of patients with differing signs and symptoms of advanced kidney disease and differing clinical presentations at the time of dialysis initiation. We hypothesized that survival might differ based on the presence of different types of clinical signs and symptoms around the time of dialysis initiation but also according to how sick patients were at the time of initiation.
MATERIALS AND METHODS

Study design and participants
This study was conducted among a previously described national cohort of 1691 patients for whom the decision to initiate chronic dialysis was made at a Veterans Affairs (VA) medical center between Fiscal Years 2000 and 2009. 17 A detailed review of the VA-wide electronic medical record (VistaWeb) was performed to ascertain the presenting signs and symptoms around the time of dialysis initiation and whether patients appeared to be acutely ill, as documented in provider notes. The electronic medical records of all patients were reviewed by a practicing nephrologist (A.M.O). Two senior nephrology fellows (M.K.Y. and S.P.W) independently reviewed the electronic medical records of a random sample of 50 of these patients to assess inter-rater reliability, which ranged from 0.51 (moderate agreement) to 0.82 (near perfect agreement) across measures. 18 
Exposure
The primary exposure was a multidimensional assessment based on chart review of each patient's clinical presentation at the time of dialysis initiation, which was characterized based on: (1) the presence or absence of different groups of signs and symptoms; and (2) whether patients appeared to be acutely ill at the time of dialysis initiation.
Sign and/or symptom group
The signs and symptoms of kidney failure around the time of dialysis initiation described in the chart were categorized inductively as follows: gastrointestinal (including anorexia and weight loss), cardiopulmonary (including edema), fatigue and/or weakness, electrolyte abnormalities, neurologic (including insomnia), and other (including bleeding, hiccups, pruritus, and uremia without mention of specific symptoms). Patients could have signs and/or symptoms of kidney failure in more than one category. The approach to sign/symptom ascertainment and classification has been described previously. 17 
Illness acuity
Based on the results of chart review, patients were categorized into three mutually exclusive groups based on how sick they appeared to be: (1) those who initiated dialysis in the outpatient setting (outpatients) (2) those who initiated dialysis in the inpatient setting but who did not appear to be acutely ill, and (3) those who initiated dialysis in the inpatient setting and were acutely ill at the time of initiation. Patients were considered to be acutely ill if chart documentation suggested that they had experienced an acute worsening of their clinical condition around the time of dialysis initiation irrespective of whether the acute illness was related to their kidney disease. Patients who were electively admitted to the hospital for dialysis initiation were not considered to be acutely ill, unless there was an acute worsening in their condition prior to dialysis initiation.
Outcome
The main outcome was death within 1 year of dialysis initiation. Dates of dialysis initiation were ascertained from the electronic medical record. Dates of death were ascertained from the VA Vital Status file.
Covariates
From VA administrative files, we obtained information on each patient's age, sex, and race (white vs. nonwhite). Using a combination of VA inpatient and outpatient treatment files and Medicare claims, we ascertained information on the presence of specific comorbid conditions (diabetes mellitus, ischemic heart disease, congestive heart failure, peripheral vascular disease, stroke, and chronic obstructive pulmonary disease) and the number of outpatient nephrology clinic visits in the year before initiation. We calculated a risk score for each patient using the Diagnosis Cost Groups model. 19 Measures of serum creatinine in the 1-year period before dialysis initiation were obtained from the VA DSS Laboratory Results file. We calculated each patient's eGFR at dialysis initiation using the four-variable Modification of Diet in Renal Disease equation, 20 based on the most recent serum creatinine drawn between 1 and 45 days before initiation. If no previous values were available, we used the first serum creatinine obtained on the day of initiation to estimate GFR. eGFR slope was estimated using a mixed model of all inpatient and outpatient creatinine values in the 1-year period before dialysis initiation. We ascertained the dialysis modality and type of dialysis access used at dialysis initiation from the electronic medical record.
Analyses
We compared patient characteristics across categories of different groups of signs and/or symptoms and illness acuity using one-way ANOVA, Kruskal-Wallis, and chisquared tests. Because the risk of mortality was not proportional during the year after dialysis initiation, we used logistic regression models to examine adjusted associations between aspects of the clinical presentation and the RR of mortality at 1 year. Risk ratios were estimated from the average predicted probabilities of death from logistic regression models. We chose to present results as a RR rather than an odds ratio due to the high frequency of this outcome in some groups. Model 1 was adjusted for sign and/or symptom groupings and all previously mentioned covariates. Model 2 was additionally adjusted for illness acuity. Effect modification in the association between clinical presentation and mortality was examined in Model 2 analyses by stratification for the following variables: age (<60, 60-70, and >70 years), race, comorbid conditions, eGFR at dialysis initiation, and tertile of risk score. There were too few women in this study to support sex-stratified analyses. We also performed sensitivity analyses to evaluate the associations between sign and/or symptom group and mortality, stratified by acuity of illness. Statistical analyses were performed using Stata software, version 14 (Stata Corp., College Station, TX, USA). This study was approved by the Institutional Review Board of the VA Puget Sound Health Care System.
RESULTS
Cohort characteristics
Sign and/or symptom group Demographic characteristics did not vary meaningfully across different groupings of signs and/or symptoms or levels of illness acuity (Tables 1 and 2 ). As reported previously, 17 the most common sign and/or symptom groups around the time of dialysis initiation were gastrointestinal (50.9%) and cardiopulmonary (48.7%), followed by fatigue/weakness (37.8%), electrolyte abnormality (18.2%), other (21.1%), and neurologic (16.6%). Cardiopulmonary signs and/or symptoms at dialysis initiation were more common among patients with a history of diabetes mellitus, ischemic heart disease, congestive heart failure, or chronic obstructive pulmonary disease. The other sign and/or symptom groups did not seem to vary greatly across different comorbid conditions. Patients with cardiopulmonary signs and/or symptoms had the highest mean eGFR at initiation (11.0 AE 6.3 mL/min/1.73 m 2 ). The proportion of patients that initiated dialysis via a hemodialysis catheter was highest for those with electrolyte abnormalities (81.1%) and neurologic signs and/or symptoms (77.9%).
Illness acuity
Overall, 427 patients (25.3%) initiated dialysis as an outpatient, 423 (25.0%) initiated dialysis as an inpatient but were not acutely ill, and 841 (49.7%) initiated dialysis as an inpatient and were acutely ill. Patients who were acutely ill at dialysis initiation were more likely to have ischemic heart disease, congestive heart failure, or chronic obstructive pulmonary disease and had the highest median risk score (2.5 [IQR 1.6, 3.5]) compared with patients who were not acutely ill (median risk score 1.9 [IQR 1.3, 2.8] for those who initiated dialysis in the hospital and 1.7 [IQR 1.1, 2.5] for those who initiated dialysis in the outpatient setting, P < 0.001). Mean eGFR at initiation was highest for patients who initiated dialysis as an outpatient (10.9 AE 5.0 vs. 9.9 AE4.8 mL/min/1.73 m 2 for inpatients who were not acutely ill and 10.4 AE 6.3 mL/min/1.73 m 2 for inpatients who were acutely ill, P = 0.04). Patients who were acutely ill at dialysis initiation had fewer outpatient nephrology visits over the year before initiation compared to patients who were not acutely ill. Those patients who initiated dialysis in the hospital and were acutely ill were more likely to start dialysis with a hemodialysis catheter (85.0%) compared to those who were not acutely ill (76.1%) and those who initiated dialysis in the outpatient setting (44.7%, P < 0.001).
Associations between sign and/or symptoms groups and illness acuity
The majority of patients (62.2%) had signs and/or symptoms falling under more than one grouping ( Figure 1 ). Patients with signs and/or symptoms that were categorized as gastrointestinal, cardiopulmonary, or fatigue/weakness were more commonly reported to have additional signs and/or symptoms in other categories, compared to patients with signs and/or symptoms that were categorized as electrolyte abnormalities, neurologic, or other. For patients who were acutely ill at dialysis initiation, it was more common to have documented signs and/or symptoms that were categorized as cardiopulmonary, electrolyte abnormalities, or neurologic compared with the two other acuity groups.
Associations between clinical presentation and mortality
Kaplan-Meier survival curves based on clinical presentation are shown in Figure 2 . The mortality rate was 174.2 per 1000 person-years during the year after dialysis initiation in the overall cohort (Supporting Information Illness acuity, % and/or symptom groups were associated with mortality during the first year after initiation. Patients who were acutely ill at dialysis initiation had a higher adjusted RR of 1-year mortality compared to outpatients (RR 1.57, 95% CI 1.15, 2.21). Higher illness acuity was associated with higher 1-year mortality (P for trend <0.01); however, there was no difference in 1-year mortality risk between inpatients who were not acutely ill and outpatients. In analyses stratified by illness acuity, fatigue and/or weakness was associated with a lower risk of 1-year mortality in patients who initiated dialysis as outpatients; other sign and/or symptom groups were not significantly associated with mortality in stratified analyses.
Subgroup analyses
In stratified analyses, the association between cardiopulmonary symptoms and 1-year mortality was seen in patients <60 years (RR 1.55, 95% CI 1.02, 2.39) but not in other age groups, was more pronounced in whites compared to nonwhites and among patients with vs. without individual comorbid conditions, but did not vary greatly by overall burden of comorbidity (Supporting Information Table 2 ). Associations between illness acuity and 1-year mortality were largely consistent across subgroups (Supporting Information 
DISCUSSION
In this cohort of incident dialysis patients, almost one half initiated dialysis while acutely ill in the hospital. These patients had higher mortality during the year after initiation as compared with patients who initiated dialysis in the hospital but were not acutely ill and those who initiated dialysis in the outpatient setting. While almost all patients had documentation of signs and/or symptoms of advanced kidney disease at the time of initiation, only cardiopulmonary signs and/or symptoms were associated with higher mortality during the year after initiation; none of the other sign and/or symptom groups classically associated with advanced kidney disease were associated with mortality after initiation. 21 The association between cardiopulmonary signs and/or symptoms and mortality was most pronounced among younger patients, while the association between illness acuity and mortality seemed to be more prominent in older patients and in patients with a higher burden of comorbidity.
Although the current guideline-recommended approach to dialysis decision-making focuses on the presence of uremic symptoms, 13 there is a paucity of data regarding how to use this information as well as substantial variation in real-world practices. 4 Signs and/or symptoms of uremia clearly play a critical role in dialysis decision-making in clinical practice, as illustrated by the IDEAL trial, where the majority of patients randomized to late start dialysis initiation actually started dialysis before reaching their eGFR target because of symptoms. 11 However, available evidence suggests that there is considerable heterogeneity in how information on signs and symptoms of advanced kidney disease is used in practice. Some providers view the presence of uremic symptoms as a marker of the severity of the underlying kidney disease and a trigger for dialysis initiation, whereas other providers view symptoms as a treatment target that might be addressed in a variety of ways including-but not limited to-dialysis. 4 Our study suggests that the presence of most kinds of uremic signs and/or symptoms have little intrinsic prognostic value and provides little support for using these signs and/or symptoms as a trigger for dialysis initiation. 13, 22, 23 Unfortunately, our study provides no information on the effectiveness of dialysis compared with other strategies in treating particular signs and symptoms, which would be helpful in supporting an individualized approach to dialysis initiation. 24 Cardiopulmonary signs and/or symptoms were the only type of sign/symptom that was associated with increased mortality at 1 year; inaccuracies with GFR estimation in patients with heart failure 25 might contribute to delayed dialysis initiation and worse outcomes in patients presenting with volume overload.
Although most sign and/or symptom groupings present at dialysis initiation were not strongly associated with death within 1 year after initiation, how sick patients appeared to be at the time of initiation was associated with this outcome. In this and other real-world cohorts, many patients initiate dialysis in the hospital while acutely ill. Qualitative data suggest that patients may defer dialysis multiple times earlier in their illness trajectory until they become sufficiently ill to consider it. 4 In other words, many patients need to become very sick before they are ready to begin dialysis. This is not surprising given the substantial burden and uncertain benefits of maintenance dialysis for many patients. Consistent with our findings, several prior studies have reported higher mortality [26] [27] [28] [29] and more severely impaired quality of life 30 in patients who initiate dialysis under unplanned circumstances. Prior literature is conflicted regarding associations between the clinical setting at dialysis initiation and subsequent outcomes; one study found no association between inpatient dialysis initiation and mortality, 31 whereas another study that found that dialysis initiation under suboptimal conditions (including as an inpatient) was associated with at least twice the risk of death, transfusion, or subsequent hospitalization compared with dialysis initiation under more controlled circumstances. 32 As we found that approximately one-third of inpatient dialysis starts appeared to be electively admitted for initiation, it is not surprising that inpatient status alone may not discriminate between patients with differing mortality risk. Our data suggest that regardless of the specific signs and/or symptoms present at dialysis initiation, those patients who initiate dialysis in the setting of an acute illness are less likely to survive more than a year after initiation as compared with those who are not acutely ill. This study cannot discern whether these results reflect confounding by other characteristics of those patients who initiate dialysis when acutely ill or whether delaying dialysis initiation until becoming acutely ill actually contributes to higher mortality. Nevertheless, it is possible that this kind of information may help inform decisions about timing of dialysis initiation for some patients.
Our study also suggests that global information on how sick patients are may be relatively more useful than information on the presence or absence of specific signs and symptoms of advanced kidney disease for supporting shared decisions about dialysis initiation in older patients and those with a higher comorbidity burden. The association of illness acuity with subsequent mortality seemed to be more pronounced in these two subgroups of patients, groups for whom the benefits of dialysis are least certain 2,33-37 and for whom dialysis initiation practices exhibit the greatest degree of variability. 38 This study has several limitations to consider. First, the data were limited by what was documented in the chart. Providers are likely to prioritize documentation of the most urgent signs and symptoms and may neglect documentation of milder signs and symptoms. Second, given the relatively high eGFR at dialysis initiation in this study, many participants may have been only minimally symptomatic at dialysis initiation, which might attenuate associations between symptoms and outcomes. Third, our results may not be generalizable to non-veterans, groups not well represented in this population such as women and younger adults, or patients with lower eGFR at dialysis initiation. Fourth, this study only looks at mortality at one point in time; since mortality risk is not constant after dialysis initiation, additional studies are needed to assess associations between clinical presentation and mortality at different time points. Finally, this study should not be interpreted as establishing causal associations; higher illness acuity at the time of initiation may also function as a marker for patients who are already predisposed to have a higher mortality risk.
In summary, cardiopulmonary signs and/or symptoms and how sick patients appeared to be at dialysis initiation, but not other signs and/or symptoms of classically associated with advanced kidney disease, were associated with an increased 1-year mortality risk. The presence or absence of specific sign and/or symptom categories may miss critical information on clinical context important in estimating prognosis around the time of initiation. a Adjusted for age, sex, race, diabetes mellitus, ischemic heart disease, congestive heart failure, peripheral vascular disease, stroke, chronic obstructive pulmonary disease, eGFR, eGFR slope, and risk score. b Model 1 + additional adjustment for illness acuity. EGFR = estimated glomerular filtration rate.
